Q32 Bio (QTTB) Cash from Investing Activities (2017 - 2025)
Q32 Bio's quarterly Cash from Investing Activities came in at $7.0 million in Q4 2025, up 350100.0% year-on-year from N/an in Q4 2024, and up 350100.0% quarter-over-quarter from -$2000.0 in Q4 2024.
Q32 Bio has reported Cash from Investing Activities for 9 years, with the latest figure at $7.0 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 350100.0% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (down 64.7% YoY), and the FY2025 full-year result was $7.0 million, down 64.87% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at $7.0 million, up from -$2000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $168.3 million in Q1 2022, with the low at -$108.2 million in Q3 2022.
- Average Cash from Investing Activities over 5 years is $803000.0, with a median of $49000.0 recorded in 2023.
- Year-over-year, Cash from Investing Activities tumbled 2492.09% in 2022 and surged 994300.0% in 2024.
- Tracing QTTB's Cash from Investing Activities over 5 years: stood at $43.7 million in 2021, then slumped by 58.79% to $18.0 million in 2022, then slumped by 100.01% to -$1000.0 in 2023, then sank by 100.0% to -$2000.0 in 2024, then surged by 350100.0% to $7.0 million in 2025.
- The last three Cash from Investing Activities figures came in at $7.0 million (Q4 2025), -$2000.0 (Q4 2024), and $9.9 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 9.94 Mn |
| Sep 30, 2024 | 9.94 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Mar 31, 2024 | 97,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | 17.99 Mn |
| Dec 31, 2022 | 17.99 Mn |
| Sep 30, 2022 | -108.22 Mn |
| Sep 30, 2022 | -108.22 Mn |
| Jun 30, 2022 | -41.37 Mn |
| Jun 30, 2022 | -41.37 Mn |
| Mar 31, 2022 | 168.31 Mn |
| Mar 31, 2022 | 168.31 Mn |
| Dec 31, 2021 | 43.66 Mn |
| Dec 31, 2021 | 43.66 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Jun 30, 2021 | -13.74 Mn |
| Jun 30, 2021 | -13.74 Mn |
| Mar 31, 2021 | -85.24 Mn |
| Mar 31, 2021 | -85.24 Mn |
| Dec 31, 2020 | -955,000.00 |
| Dec 31, 2020 | -955,000.00 |
| Sep 30, 2020 | 38.84 Mn |
| Sep 30, 2020 | 38.84 Mn |
| Jun 30, 2020 | 52.01 Mn |
| Jun 30, 2020 | 52.01 Mn |
| Mar 31, 2020 | 115.00 Mn |
| Mar 31, 2020 | 115.00 Mn |
| Dec 31, 2019 | -20.03 Mn |
| Dec 31, 2019 | -20.03 Mn |
| Sep 30, 2019 | -13.14 Mn |
| Sep 30, 2019 | -13.14 Mn |
| Jun 30, 2019 | -38.30 Mn |
| Jun 30, 2019 | -38.30 Mn |
| Mar 31, 2019 | 19.67 Mn |
| Mar 31, 2019 | 19.67 Mn |
| Dec 31, 2018 | 10.20 Mn |
| Dec 31, 2018 | 10.20 Mn |
| Sep 30, 2018 | -45.26 Mn |
| Sep 30, 2018 | -45.26 Mn |
| Jun 30, 2018 | -93.37 Mn |
| Jun 30, 2018 | -93.37 Mn |
| Mar 31, 2018 | 6.64 Mn |
| Mar 31, 2018 | 6.64 Mn |
| Dec 31, 2017 | -79.90 Mn |
| Dec 31, 2017 | -79.90 Mn |
| Sep 30, 2017 | -299,538.00 |
| Sep 30, 2017 | -299,538.00 |
| Jun 30, 2017 | -473,294.00 |
| Jun 30, 2017 | -473,294.00 |
| Mar 31, 2017 | -848,433.00 |
| Mar 31, 2017 | -848,433.00 |